EUVIMEDEUVIMED entdecken
Crossref

Risk of Osteoarthritis and Arthroplasty Between Baclofen and Tizanidine: A Target Trial Emulation Study

Yu-Chi Su, Yu-Chen Su, Edward Chia-Cheng Lai, Yu-Ching Lin

Clinical Drug Investigation · 2025

DOI: 10.1007/s40261-025-01448-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Drug Investigation, 2025. Verfasst von Yu-Chi Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tai…. Hauptthemen laut MEDLINE: Baclofen, Osteoarthritis, Arthroplasty, Replacement, Clonidine. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Preclinical studies have shown that baclofen may reduce the risk of osteoarthritis through its anti-inflammatory effect. OBJECTIVE: We aimed to clarify this association by comparing the risks of osteoarthritis and joint replacement surgery in patients receiving baclofen and tizanidine. METHODS: This retrospective cohort study was conducted on the global TriNetX platform (October 31, 2024). New users of baclofen and tizanidine aged ≥40 years were included in the baclofen and tizanidine group, respectively. The propensity score matching method was used. The primary outcomes were osteoarthritis and joint replacement surgery. The secondary outcomes included all-cause mortality, a composite outcome of osteoarthritis and all-cause mortality, and a composite outcome of joint replacement surgery and all-cause mortality. Cause specific hazard ratios (HRs) with 95% confidence intervals (CIs) of the outcomes were calculated with Cox regression using the TriNetX platform. RESULTS: Two well-balanced groups containing 68,210 patients each were generated by propensity score matching (age: 57.8 years; female: 55.6% in both groups). Baclofen users had a significantly lower risk of developing osteoarthritis than tizanidine users (HR: 0.965, 95% CI: 0.941 to 0.989). A similar relationship was observed for joint replacement surgery (HR: 0.847, 95% CI: 0.750 to 0.956). However, the composite outcome of osteoarthritis or death had a HR of 1.129 (95% CI: 1.109 to 1.150), and the HR of joint replacement surgery or death was 1.509 (95% CI: 1.463 to 1.556). The HR of death was 1.577 (95% CI: 1.527 to 1.629), suggesting a higher risk of mortality in the baclofen group. CONCLUSION: The surviving baclofen users had a lower risk of osteoarthritis and joint replacement surgery compared to surviving tizanidine users. However, baclofen users exhibited a higher risk of mortality than tizanidine users. Future studies are necessary to clarify the impact of baclofen on osteoarthritis and joint replacement surgery while accounting for mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BaclofenOsteoarthritisArthroplasty, ReplacementClonidineHumansFemaleMiddle AgedRetrospective StudiesMaleAgedPropensity ScoreAdult

Substanzen

BaclofentizanidineClonidine

Autor:innen und Institutionen

  • Department of Physical Medicine and Rehabilitation, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
  • Department of Ophthalmology, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
  • School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Physical Medicine and Rehabilitation, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan. yuchinglin2011@gmail.com.
  • Department of Physical Medicine and Rehabilitation, College of Medicine, National Cheng Kung University, Tainan, Taiwan. yuchinglin2011@gmail.com.
  • , 138 Sheng-Li Road, Tainan, 70403, Taiwan. yuchinglin2011@gmail.com.

Zitieren

APA

Su, Y. C., Su, Y. C., Lai, E. C., & Lin, Y. C. (2025). Risk of Osteoarthritis and Arthroplasty Between Baclofen and Tizanidine: A Target Trial Emulation Study. Clinical Drug Investigation. https://doi.org/10.1007/s40261-025-01448-5

Vancouver

Su YC, Su YC, Lai EC, Lin YC. Risk of Osteoarthritis and Arthroplasty Between Baclofen and Tizanidine: A Target Trial Emulation Study. Clinical Drug Investigation. 2025. doi:10.1007/s40261-025-01448-5

BibTeX
@article{Su2025,
  author = {Su, Yu-Chi and Su, Yu-Chen and Lai, Edward Chia-Cheng and Lin, Yu-Ching},
  title = {Risk of Osteoarthritis and Arthroplasty Between Baclofen and Tizanidine: A Target Trial Emulation Study},
  journal = {Clinical Drug Investigation},
  year = {2025},
  doi = {10.1007/s40261-025-01448-5}
}
Kostenlos starten →